Lb Pharmaceuticals Inc (LBRX)

CIK 1691082 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lb Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001193125-26-449994
Nov 5, 20268-K0001193125-26-449887
Oct 13, 202640002150267-26-000005
Oct 13, 2026SCHEDULE 13G/A0000019617-26-000360
Oct 13, 202640001746372-26-000007
Oct 5, 2026EFFECT9999999995-26-003150
Oct 1, 2026POS AM0001193125-26-410664
Oct 1, 2026S-3ASR0001193125-26-410651
Sep 24, 202630002150267-26-000003
Sep 15, 2026424B30001193125-26-391384
Sep 15, 20268-K0001193125-26-391358
Sep 14, 202630001746372-26-000005
Sep 3, 2026424B30001193125-26-381100
Sep 3, 20268-K0001193125-26-381076
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352336
Aug 11, 20268-K0001193125-26-343479
Aug 11, 202610-Q0001193125-26-343490
Aug 11, 2026424B30001193125-26-343542
Aug 3, 202640001193125-26-331058
Jul 29, 2026SCHEDULE 13G/A0002012383-26-002809
Jul 29, 2026424B30001193125-26-322276
Jul 29, 20268-K0001193125-26-322208
Jul 22, 20268-K0001193125-26-311357
Jul 22, 2026424B30001193125-26-311394
Jul 16, 2026SCHEDULE 13G0000019617-26-000264